BeStock  
股票 › 药品制造-专科与仿制 › ZTS

硕腾 ZTS

美股市值排名 #630药品制造-专科与仿制
$79.40 −$2.71 (-3.30%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $79.45 +0.06%
开盘$79.00
昨收$82.11
当日区间$78.63 – $80.67
成交量6.02M
市值$32.26B
市盈率（TTM）13.4
股息率2.63%

股权结构与仓位

谁在持有、谁在做空，以及大资金的流向

机构持股比例98.2%-0.50 个百分点，较上季度
持仓机构数1,783-37 ，较上季度
内部人近期交易41次买入 / 5次卖出净买入
空头持仓比例4.24% 占流通股回补天数 4.1 · 截至 15 Oct 2026
卖空成交量占比14.0%近5日成交量平均占比

卖空成交量占当日成交量比例

9%14%18%23%Sep '26Oct '26Nov '26

大单净流入，近20个交易日

大单买入减卖出的净额（美元）。该窗口期内：−$48.65M（7个净流入日，13个净流出日）。

按单量净流入，近20个交易日

−$41.1M超大单−$7.6M大单−$9.0M中单−$25.1M小单

超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。

已披露的前五大股东合计持有30.8%的流通股。

最大股东

  • BlackRock9.54%
  • Vanguard Capital Management, LLC6.87%
  • Vanguard Portfolio Management, LLC5.77%
  • State Street Global Advisors4.76%
  • State Farm Mutual Automobile Insurance Company3.85%
  • Geode Capital Management, LLC3.21%
  • Wellington Management Group2.28%
  • UBS Asset Management1.83%

按投资者类型

  • Mutual Fund75.11%
  • Private Company7.44%
  • Public Company5.28%
  • Hedge Fund5.11%
  • Government Pension Fund2.27%
  • Sovereign Wealth Fund1.16%
  • Family Office/Trust0.54%
  • VC/PE Fund0.47%

过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从5.09%降至4.24%。

近期机构持仓变动

股东类型期间持股变动新持股比例
Confluence Investment Management LLC Mutual Fund 2026/Q3 +1,398,638 0.5%
Deka Investment GmbH Mutual Fund 2026/Q3 +805,491 0.3%
Flossbach von Storch SE Mutual Fund 2026/Q3 +4,210,978 1.0%
BlackRock Mutual Fund 2026/Q3 +3,845,869 9.5%
Citadel Advisors LLC Hedge Fund 2026/Q3 +2,687,252 0.8%
Qube Research & Technologies Ltd Mutual Fund 2026/Q3 +2,279,333 0.6%
Jane Street Group, LLC Private Company 2026/Q3 +2,004,257 0.5%
Geode Capital Management, LLC Mutual Fund 2026/Q3 +1,940,374 3.2%
Brandes Investment Partners, LP Mutual Fund 2026/Q3 +1,930,651 0.5%
Victory Capital Management Inc. Mutual Fund 2026/Q3 +1,827,686 0.5%
Carmignac Gestion SA Mutual Fund 2026/Q3 +1,575,700 0.4%
Voloridge Investment Management, LLC Hedge Fund 2026/Q3 +1,562,993 0.6%
Pacer Advisors, Inc. Mutual Fund 2026/Q3 +1,390,737 0.4%
Invesco Ltd. Mutual Fund 2026/Q3 +1,286,715 0.5%
Smead Capital Management, Inc. Mutual Fund 2026/Q3 +1,233,210 0.3%

按报告期列出的机构买卖动态，变动幅度从大到小排列。

内部人交易

日期内部人职位交易类型股数价格交易后持股
8 Oct 2026 Kristin Peck Chief Executive Officer Other Derivative Acquisition +720 – 66,915
8 Oct 2026 Roxanne Lagano General Counsel Other Derivative Acquisition +367 – 31,315
8 Oct 2026 Abhay Nayak Executive VP & President of U.S. Commercial Operations Other Derivative Acquisition +321 – 5,022
8 Oct 2026 Julie Fuller Executive VP, Chief Human Resources Officer & Global Operations Other Derivative Acquisition +367 – 2,480
8 Oct 2026 Jeannette Astorga Executive VP of Corporate Affairs & Chief Sustainability Officer Other Derivative Acquisition +52 – 2,349
8 Oct 2026 Rimma Driscoll EVP of Global Strategy, Portfolio Mkt, Busi. Dev Human Health and Platinum Per. Other Derivative Acquisition +277 – 6,551
8 Oct 2026 Keith Sarbaugh Executive VP & Chief Digital and Technology Officer Other Derivative Acquisition +303 – 2,668
8 Oct 2026 Kevin Esch Executive VP and President of Research & Development Other Derivative Acquisition +360 – 1,167
29 Sep 2026 Julie Fuller Executive VP, Chief Human Resources Officer & Global Operations Derivative Exercise and Sale -274 $69.83 1,588
29 Sep 2026 Julie Fuller Executive VP, Chief Human Resources Officer & Global Operations Derivative Exercise and Retained +525 – 1,588
16 Sep 2026 Mark Stetter Independent Director Other Derivative Acquisition +342 – 880
30 Aug 2026 James Saccaro Chief Financial Officer Other Derivative Acquisition +81,063 – 81,063
6 Aug 2026 Frank D'Amelio Independent Director Other Disposition -6,650 – 21,458
9 Jul 2026 Wetteny Joseph Special Advisor to the CEO Other Derivative Acquisition +363 – 10,155
9 Jul 2026 Kristin Peck Chief Executive Officer Other Derivative Acquisition +616 – 66,195
9 Jul 2026 Roxanne Lagano General Counsel Other Derivative Acquisition +314 – 30,947
9 Jul 2026 Abhay Nayak Executive VP & President of U.S. Commercial Operations Other Derivative Acquisition +214 – 4,701
9 Jul 2026 Julie Fuller Executive VP, Chief Human Resources Officer & Global Operations Other Derivative Acquisition +314 – 2,113
9 Jul 2026 Jeannette Astorga Executive VP of Corporate Affairs & Chief Sustainability Officer Other Derivative Acquisition +45 – 2,296
9 Jul 2026 Rimma Driscoll EVP of Global Strategy, Portfolio Mkt, Busi. Dev Human Health and Platinum Per. Other Derivative Acquisition +237 – 6,273

数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。

空头持仓（按报告期）

报告日期空头股数占流通股比例回补天数
15 Oct 2026 17,520,176 4.2% 4.1
30 Sep 2026 18,424,459 4.5% 4.1
15 Sep 2026 17,390,071 4.2% 3.8
31 Aug 2026 19,430,882 4.7% 4.1
14 Aug 2026 16,781,231 4.1% 2.0
31 Jul 2026 21,352,028 5.1% 3.9

讨论区

暂无评论——快来第一个聊聊 ZTS。

发表评论

Scroll to Top